• Ipsos
  • Therapy Insights Centres of Expertise

Therapy Insights Centres of Expertise

SELECT A RUBRIC

Oncology CoE | Autoimmune CoE | Virology & Vaccines CoE
Respiratory CoE | Diabetes & Obesity CoE | Rare diseases CoE

Oncology centre of expertise

The oncology treatment landscape is evolving at an increasingly rapid pace, creating knowledge gaps with each new fast-tracked approval and change in standard of care.

Our Oncology CoE harnesses and integrates the vast oncology market research knowledge, resources and real-world evidence from across the Ipsos globe – ensuring that the best expertise, insights and approaches are available to our clients wherever they are in the world.

Why Ipsos for oncology?

  • Oncology is Ipsos’ #1 therapy area of focus.
  • We have dedicated custom and syndicated oncology teams worldwide.
  • Our Global Oncology Monitor is the most comprehensive global syndicated database of anti-cancer drug treatment, covering all tumour types.
  • Our custom oncology experience spans the pharmaceutical product lifecycle.
  • We have Market Access experts based in the US, Europe and Asia-Pacific.
  • We work with 60+ oncology clients, including the leading oncology manufacturers.

Our global offer in oncology

  • Custom research: A vast array of oncology market research approaches and data analytics to answer business questions across the product lifecycle.
  • Syndicated solutions: Real-world evidence on cancer treatment in 30+ countries, monitors on the changing dynamics of the oncology diagnostics market, topical oncology studies & more.
  • Market access/HEOR: The complete spectrum of oncology market access services, powered by payer insights, economic modelling, and Global Oncology Monitor data.
  • Advisory services: Fact-based strategies that inform critical decisions across the clinical, medical and commercial lifecycle.

Recent thought leadership

Learn more

Contact: Jackie Ilacqua

Autoimmune centre of expertise

Over the past 7 years, the treatment paradigm for autoimmune and inflammatory diseases has undergone a sea of change…

From the dominance of one biologic therapy class, we now have a vast and growing number of treatment options – from advanced therapies including biosimilars, to newer therapy classes with more targeted modes of action. At the same time, many treatments are expanding into new indications.

About Ipsos’ Autoimmune CoE

Against this backdrop, Ipsos’ many immunology experts – including specialists in rheumatology, gastroenterology, dermatology, Multiple Sclerosis and other diseases – provide custom research insights and syndicated real-world evidence in 10 diseases to guide the decision-making of clients in the autoimmune market.

Our global autoimmune research offer

  • Custom research: A vast array of custom market research approaches to answer business questions across the pharmaceutical product lifecycle, with teams specialising in ethnography, behavioural science, patient communities, data science, and more.
  • Syndicated solutions: Global Therapy Monitors providing real-world evidence on prescribing and treatment management in 10 autoimmune diseases; autoimmune patient communities; conference research; and AI topics & trends studies including COVID-19 and JAK regulatory impact.
  • Market access/HEOR: The complete spectrum of market access services, powered by payer insights, economic modelling, and real-world evidence in autoimmune diseases.
  • Advisory services: Fact-based strategies that inform critical decisions across the clinical, medical and commercial lifecycle.

Recent thought leadership

Learn more

Contact: [email protected]

Virology & Vaccines centre of expertise

Visit Ipsos’ Vaccines web page

The COVID-19 pandemic has reinforced the ever-present threat of viral diseases – and the importance of vaccines and antivirals in managing them.

Ipsos’ Virology & Vaccines CoE works with clients focused on the development of antivirals and vaccines aimed at combatting such diseases.

With virology & vaccines experts worldwide – many of whom have devoted their careers to understanding this complex market – we provide real-world evidence and custom market research insights to guide clients’ decision-making across the pharmaceutical product lifecycle.

Our global offer

  • Custom research: A vast array of custom market research approaches to answer business questions on all aspects of pharmaceutical marketing.
  • Syndicated solutions: Global Therapy Monitors providing real-world evidence on prescribing and treatment management in multiple virological conditions including COVID-19; Syndicated Vaccine Impact Study among healthcare professionals, pharmacists & consumers; and topical studies including consumer perspectives on COVID-19 therapeutics.
  • Market access/HEOR: The complete spectrum of market access services, powered by payer insights, economic modelling and Ipsos’ real-world evidence.
  • Advisory Services: Fact-based strategies that inform critical decisions across the clinical, medical and commercial lifecycle
  • Thought Leadership: Ongoing research into the impact of the COVID-19 pandemic on disease treatment and management, vaccine uptake, and related issues.

Recent thought leadership

Learn more

Contact: Rhoda Schmuecking

Respiratory centre of expertise

Expanded indications and licences, plus new biologic therapies and combinations, continue to broaden effective treatment solutions for patients with common respiratory diseases.

Ipsos’ Respiratory CoE comprises respiratory disease experts worldwide delivering syndicated real-world evidence, custom market research insights and advisory services to inform the decision-making of our clients working in the respiratory disease space.

Our global offer

  • Custom research: A vast array of custom market research approaches to answer business questions across the pharmaceutical product lifecycle.
  • Syndicated solutions: Global Therapy Monitors providing real-world evidence on prescribing and treatment management in multiple respiratory indications; respiratory patient communities; respiratory conference assessment studies, and more.
  • Market access/HEOR: The complete spectrum of market access services, powered by payer insights, economic modelling, and real-world evidence in respiratory diseases.
  • Advisory Services: Fact-based strategies that inform critical decisions across the clinical, medical and commercial lifecycle

Recent thought leadership

Learn more

Contact: Rhoda Schmuecking

Diabetes & Obesity centre of expertise

Next generation treatments for diabetes are now most viable when they combine efficacy at regulating blood sugar with cardiovascular protection and treatment for chronic kidney disease.

The bar is also rising for insulin treatments, as novel formulations promise less frequent dosing, and technological advances could eventually provide automatic dosing and blood glucose monitoring.

Meanwhile, obesity continues to be considered a lifestyle condition, creating major barriers for pharmaceutical treatments – yet newly launched and pipeline products with superior efficacy could change the treatment paradigm.

The Ipsos Diabetes CoE

Ipsos’ Diabetes & Obesity CoE provides market research insights and advisory services to help our clients navigate these evolving treatment landscapes. We harness relevant expertise and data from across the Ipsos globe, striving to ensure excellence in the provision of information to help our biopharma and medical device clients address these widespread conditions.

Our Global Offer

  • Qualitative services: Our qualitative market research capabilities address questions across the product lifecycle and include market landscaping, KOL research, patient journey research, webcam & virtual ethnography, immersions and communications testing.
  • Quantitative services: Our quantitative market research capabilities support decision-making on all aspects of pharmaceutical marketing, and include market sizing, patient journey research, chart audits, concept testing, launch material testing, brand and salesforce performance and optimisation tracking, and much more.
  • Market Access/HEOR: We offer the complete spectrum of market access services, powered by payer insights and economic modelling.
  • Advisory services: Our advisory specialists can answer macro business questions by leveraging a unique combination of expertise, resources, coverage and strong partnerships with diabetes foundations.
  • Syndicated solutions: Real-world evidence on diabetes treatment in APAC and MENA, with other markets on demand.
  • Centres of Expertise: We can involve specialists in healthcare product lifecycle stages, innovative approaches, and specific healthcare markets including Digital & Connected Health & Medical Devices & Diagnostics.

Contact: Scott Morano

Rare diseases centre of expertise

Healthcare systems are primarily set up to address common diseases, which means information gaps often exist around the diagnosis, treatment and patient experience of a rare disease.

Ipsos has an extensive track record in rare diseases market research. Our specialists provide custom solutions, real-world evidence and advisory services to help our clients navigate, and ultimately benefit, disease areas with small patient populations and high unmet needs.

Download our brochure – ‘Rare Diseases CoE: Six Stories of Success’ – to see examples of our work.

Our rare diseases portfolio

  • Syndicated real-world evidence: Ipsos’ Global Therapy Monitors track treating doctors’ awareness and perceptions of current and pipeline products, compare perceptions with actual prescribing, and much more.
  • Recruitment expertise & respondent access: Ipsos works with multiple recruitment partners (including rare disease and creative recruitment specialists) and has extensive experience in reaching and engaging the right respondents via advocacy groups, patient forums and physician referrals.
  • Qualitative services: Our qualitative market research capabilities can be used to address questions across the pharmaceutical product lifecycle and include market landscaping, KOL research, patient journey research, webcam & virtual ethnography, immersions and testing of communication & disease education materials.
  • Quantitative services: Our quantitative market research capabilities provide a robust foundation for decision-making on all aspects of pharmaceutical marketing, and include market sizing, treatment and referral mapping, patient journey research, chart audits, usage and awareness tracking, message recall testing of communication & disease education materials, and more.
  • Specialist services: We apply in rare diseases the specialist expertise of our teams dedicated to commercial strategy and to global evidence, value & market access, including preparing research results for publication.
  • Advisory services: Our specialists can answer your macro business questions by leveraging a unique combination of expertise, resources, coverage & connections.

Recent thought leadership

Contact: Lynda Levy